Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tejnaksh HealthcareBOM:539428 -1.72%72 ROA % is 4.81% as of Mar. 2026, which is 44% below its 10-year median of 8.58. GuruFocus rates BOM:539428 with a GF Score™ of 72/100 and a GF Value™ of ₹20.94 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks better than 61.76% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tejnaksh Healthcare's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹14.4 Mil.
Tejnaksh Healthcare's average Total Assets over the quarter that ended in Mar. 2026 was ₹300.5 Mil. Therefore, Tejnaksh Healthcare's annualized ROA % for the quarter that ended in Mar. 2026 was 4.81%.
The historical rank and industry rank for Tejnaksh Healthcare's ROA % or its related term are showing as below:
BOM:539428'
s ROA % Range Over the Past 10 Years
Min: 4.05 Med: 8.58 Max: 16.2
Current: 4.05
During the past 12 years, Tejnaksh Healthcare's highest ROA % was 16.20%. The lowest was 4.05%. And the median was 8.58%.
BOM:539428's ROA % is ranked better than 61.76% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.84
vs BOM:539428: 4.05
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Tejnaksh Healthcare ROA % Related Terms
Tejnaksh Healthcare ROA % Historical Data
* Premium members only.
The historical data trend for Tejnaksh Healthcare's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Tejnaksh Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tejnaksh Healthcare ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's ROA % distribution charts can be found below:
* The bar in red indicates where Tejnaksh Healthcare's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Tejnaksh Healthcare (BOM:539428) has a ROA % of 4.81% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tejnaksh Healthcare and its competitors. This is 44% below median its historical median of 8.58. Over the past decade, Tejnaksh Healthcare's ROA % has ranged from 4.05 to 16.20. According to the industry distribution chart, Tejnaksh Healthcare ranks #260 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 38.2%.
Is Tejnaksh Healthcare's ROA % too high?
Tejnaksh Healthcare's current ROA % of 4.81% is 44% below median its 10-year median of 8.58. Over the past 10 years, this metric has ranged from a low of 4.05 to a high of 16.20. The Healthcare Providers & Services industry median ROA % is 1.84. Tejnaksh Healthcare's value of 4.81% is 161.4% above this industry median. Based on the distribution chart, Tejnaksh Healthcare ranks #260 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Tejnaksh Healthcare has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #260 out of 680 companies for ROA %. This puts Tejnaksh Healthcare in the upper half of its industry. The industry median ROA % is 1.84. Tejnaksh Healthcare's value of 4.81% is 161.4% above this benchmark. Historically, Tejnaksh Healthcare's own ROA % has ranged from 4.05 to 16.20 over the past decade. While the company's 10-year median is 8.58 vs. the industry median of 1.84, Tejnaksh Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.84, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tejnaksh Healthcare's current ROA % of 4.81% is 161.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current ROA % is 4.81%, which is 44% below median its own 10-year median of 8.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.94, compared to a current price of ₹13.72 — trading 34.5% below its estimated fair value. The current ROA % is 4.81%, which is 44% below median its 10-year median of 8.58 and 161.4% above the Healthcare Providers & Services industry median of 1.84. Tejnaksh Healthcare's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current ROA % is 4.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?
Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued.
The current stock price of ₹13.72 is trading 34.5% below its estimated GF Value™ of ₹20.94.
GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.
Key valuation signals for BOM:539428:
ROA %: 4.81% (44% below median its 10-year median of 8.58)
GF Value™: ₹20.94 vs. price of ₹13.72 (34.5% below fair value)
Industry Position: 161.4% above the Healthcare Providers & Services median (#260 of 680)
No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
72GF Score
Get the complete analysis for BOM:539428
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539428 has been successfully added to your 
